STERIS plc (NYSE:STE) Shares Purchased by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. grew its position in STERIS plc (NYSE:STE - Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 123,921 shares of the medical equipment provider's stock after buying an additional 28,859 shares during the period. Rockefeller Capital Management L.P. owned 0.13% of STERIS worth $25,475,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Avalon Trust Co purchased a new position in STERIS in the fourth quarter worth approximately $30,000. Human Investing LLC purchased a new position in shares of STERIS during the 4th quarter worth $31,000. Anfield Capital Management LLC increased its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division raised its holdings in STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its holdings in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

STE has been the subject of a number of recent analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Stephens reissued an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, April 10th. Finally, Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, STERIS has an average rating of "Moderate Buy" and an average target price of $258.75.

STERIS Stock Performance

Shares of NYSE STE traded up $2.51 during mid-day trading on Friday, hitting $222.53. 451,315 shares of the company were exchanged, compared to its average volume of 527,798. The stock has a 50 day simple moving average of $222.48 and a 200-day simple moving average of $219.19. STERIS plc has a 1-year low of $197.84 and a 1-year high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm has a market cap of $21.86 billion, a price-to-earnings ratio of 47.25 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS's dividend payout ratio (DPR) is presently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.